Cidara Therapeutics Inc (CDTX)

14.48 +0.58 (+4.17%) USD  |  NASDAQ  |  Nov 14, 16:00
14.66 +0.18 (+1.24%) After-Hours: 20:00
More

Cidara Therapeutics Research and Development Expense (Quarterly): 12.43M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
September 30, 2024 12.43M
June 30, 2024 6.657M
March 31, 2024 11.59M
December 31, 2023 39.78M
September 30, 2023 10.39M
June 30, 2023 8.657M
March 31, 2023 18.87M
December 31, 2022 21.94M
September 30, 2022 20.04M
June 30, 2022 15.26M
March 31, 2022 20.17M
December 31, 2021 19.01M
September 30, 2021 20.50M
June 30, 2021 17.72M
March 31, 2021 15.85M
December 31, 2020 21.13M
September 30, 2020 16.26M
June 30, 2020 17.63M
March 31, 2020 13.00M
December 31, 2019 11.49M
September 30, 2019 11.50M
June 30, 2019 10.74M
Date Value
March 31, 2019 12.67M
December 31, 2018 13.05M
September 30, 2018 11.28M
June 30, 2018 11.62M
March 31, 2018 13.20M
December 31, 2017 10.23M
September 30, 2017 9.159M
June 30, 2017 13.19M
March 31, 2017 10.24M
December 31, 2016 11.31M
September 30, 2016 8.729M
June 30, 2016 8.471M
March 31, 2016 7.189M
December 31, 2015 7.564M
September 30, 2015 6.766M
June 30, 2015 4.21M
March 31, 2015 4.935M
December 31, 2014 3.474M
September 30, 2014 1.992M
June 30, 2014 0.966M
March 31, 2014 0.278M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

6.657M
Minimum
Jun 2024
39.78M
Maximum
Dec 2023
16.92M
Average
16.95M
Median

Research and Development Expense (Quarterly) Benchmarks

Biomarin Pharmaceutical Inc 184.90M
Arbutus Biopharma Corp 14.27M
GlycoMimetics Inc 6.286M
FibroGen Inc 34.11M
Cue Biopharma Inc 9.53M